Pay in 4 interest-free payments of $6.03 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
You may also need medical intervention to help you reach a healthy weight
Disclaimers: *These statements have not ben evaluated by the FDA
The analysis included eight randomized controlled trials with 2,372 participants (all with BMI 27 kg/m) and found that weight regain was proportional to the amount initially lost.48 On average, participants who had taken liraglutide regained 2.2 kg, while those who had taken semaglutide or tirzepatide regained 9.69 kg after stopping the medication.48 Similarly, a 2025 review in Biomolecules showed that patients treated with GLP-1 or dual GLP-1/GIP agonists experience substantial weight loss (ranging from about 6% to over 20%) but also significant weight regain upon drug discontinuation
Cardiovascular outcomes, laboratory profile, and tolerability with oral semaglutide: [PMID: 33439583] Laboratory literature summary: Cardiovascular outcomes, laboratory profile, and tolerability with oral semaglutide: insights for managed care
Semaglutide 2.4 mg: the latest GLP-1RA approved for obesity
US$ 22.78
US$ 25.18
US$ 29.00
US$ 22.61
